Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index, and 1 are not checked yet.

Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial

Rothberg, Rebecca L, Azhari, Nour, Haug, Nancy A, Dakwar, Elias · 2021 · Journal of Psychopharmacology

Abstract

Background: Sub-anesthetic ketamine administration may be helpful for substance use disorders. Converging evidence suggests that the efficacy of ketamine for certain conditions may implicate a subset of its psychoactive effects. Aims: The aim of this analysis is to evaluate whether the mystical-type effects of ketamine are critical for clinical efficacy in alcohol-dependent individuals. In this secondary analysis, we determine if a subset of the psychoactive effects of ketamine, the so-called mystical-type experience, mediates the effect of ketamine, when combined with motivational enhancement therapy, on at-risk drinking behavior in alcohol-dependent individuals interested in treatment. Methods: Forty alcohol dependent adults were randomized to either a 52-minute infusion of ketamine or midazolam, which they received on a designated quit-day during the second week of a five-week motivational enhancement therapy regimen. Psychoactive effects were assessed following the infusion, and alcohol use was monitored for the subsequent 3 weeks at each twice-weekly visit. Results: We found that ketamine leads to significantly greater mystical-type effects (by Hood Mysticism Scale) and dissociation (by Clinician Administered Dissociative States Scale) compared to the active control. Ketamine also led to significant reduction in at-risk drinking. The Hood Mysticism Scale, but not Clinician Administered Dissociative States Scale score, was found to mediate the effect of ketamine on drinking behavior. Conclusions: This trial adds evidence to the literature on the importance of mystical-type experiences in addiction treatment. Future research should continue to investigate the relationship between the psychoactive effects of psychedelic therapeutics and clinical outcomes for other substance use and mental health disorders.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881120970879

Cites

59 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 59 references

Research works printed but not linked: 7

  1. Borgonovi R, 2014, Aldous Huxley Annual, 12, 72
  2. Burns L, 2002, J Trauma Stress, 68, 299
  3. Centers for Disease Control and Prevention (CDC), 2013, Alcohol Related Disease Impact (ARDI) Application
  4. Escohotado A, 1999, A Brief History of Drugs: From the Stone Age to the Stoned Age, 114
  5. McHugh RK, 2010, Psychiatr Clin, 33, 511
  6. National Highway Traffic Safety Administration, 2017, Traffic Safety Facts: Alcohol-Impaired Driving, 1
  7. Pahnke WN, 1966, Int J Parapsychol, 8, 295

Cited by

See all 101

Metadata

Authors
Rothberg, R. L., Azhari, N., Haug, N. A., & Dakwar, E.
Affiliations
  • Palo Alto University (US)
  • Columbia University Irving Medical Center (US)
Corresponding author
Dakwar, Elias
Venue
Journal of Psychopharmacology
Published
2020-12-13
Volume
35
Issue
2
Pages
150-158
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W3111975240
Cited by
97
References
59
Citations by year
2026: 13 · 2025: 20 · 2024: 25 · 2023: 12 · 2022: 19 · 2021: 8
FWCI
3.91
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (AA023010)
  • National Institute on Drug Abuse (DA031771)
  • New York State Psychiatric Institute
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
ketamine, hazardous drinking, alcoholism, motivational enhancement therapy, dissociation, psychoactive effects, mediation, midazolam, alcoholism treatment
MeSH terms
Alcohol Drinking, Dissociative Disorders, Double-Blind Method, Female, Hallucinogens, Humans, Ketamine, Male, Midazolam, Middle Aged, Mysticism, Surveys and Questionnaires, Behavior, Addictive, Treatment Outcome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial. https://app.cochat.ai/papers/10.1177/0269881120970879
The paper
Rothberg, R. L., Azhari, N., Haug, N. A., & Dakwar, E. (2021). Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial. Journal of Psychopharmacology. https://doi.org/10.1177/0269881120970879

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.